Darren K McGuire

Darren K McGuire

UNVERIFIED PROFILE

Are you Darren K McGuire?   Register this Author

Register author
Darren K McGuire

Darren K McGuire

Publications by authors named "Darren K McGuire"

Are you Darren K McGuire?   Register this Author

100Publications

2905Reads

-Profile Views

FDA guidance on antihyperglyacemic therapies for type 2 diabetes: One decade later.

Diabetes Obes Metab 2019 May 12;21(5):1073-1078. Epub 2019 Mar 12.

Clinical Development, Therapeutic Area Cardiometabolism, Boehringer Ingelheim, Ingelheim, Germany.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1111/dom.13645DOI Listing
May 2019

Age at Diagnosis of Type 2 Diabetes Mellitus and Associations With Cardiovascular and Mortality Risks.

Circulation 2019 May;139(19):2228-2237

Department of Molecular and Clinical Medicine, Institute of Medicine, University of Gothenburg, Sweden (Araz Rawshani, A. Rosengren, S.G.).

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1161/CIRCULATIONAHA.118.037885DOI Listing
May 2019

Relative Prognostic Importance and Optimal Levels of Risk Factors for Mortality and Cardiovascular Outcomes in Type 1 Diabetes Mellitus.

Circulation 2019 Apr;139(16):1900-1912

Department of Molecular and Clinical Medicine, Institute of Medicine, University of Gothenburg, Sweden (A. Rawshani, A. Rawshani, B.E., A. Rosengren, S.G.).

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1161/CIRCULATIONAHA.118.037454DOI Listing
April 2019

Antithrombotic treatment gap among patients with atrial fibrillation and type 2 diabetes.

Int J Cardiol 2019 Apr 30. Epub 2019 Apr 30.

Duke Clinical Research Institute, Duke University School of Medicine, Durham, NC, USA. Electronic address:

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.ijcard.2019.04.085DOI Listing
April 2019

Management of patients with diabetes and heart failure with reduced ejection fraction: An international comparison.

Diabetes Obes Metab 2019 02 25;21(2):261-266. Epub 2018 Sep 25.

Saint Luke's Mid America Heart Institute and University of Missouri-Kansas City, Kansas City, Missouri.

View Article

Download full-text PDF

Source
http://doi.wiley.com/10.1111/dom.13511
Publisher Site
http://dx.doi.org/10.1111/dom.13511DOI Listing
February 2019

Heart Failure Epidemiology in Patients With Diabetes Mellitus Without Coronary Heart Disease.

J Card Fail 2019 Feb 10;25(2):78-86. Epub 2018 Nov 10.

Cardiology Division, Stony Brook University, Stony Brook, New York, United States. Electronic address:

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.cardfail.2018.10.015DOI Listing
February 2019

Probing for Vulnerable Plaque in Patients With Diabetes Mellitus.

Arterioscler Thromb Vasc Biol 2019 Feb;39(2):124-125

From the Division of Cardiology, Department of Internal Medicine, University of Texas Southwestern Medical Center, Dallas.

View Article

Download full-text PDF

Source
https://www.ahajournals.org/doi/10.1161/ATVBAHA.118.312227
Publisher Site
http://dx.doi.org/10.1161/ATVBAHA.118.312227DOI Listing
February 2019

Dapagliflozin and Cardiovascular Outcomes in Type 2 Diabetes.

N Engl J Med 2019 01 10;380(4):347-357. Epub 2018 Nov 10.

From the Thrombolysis in Myocardial Infarction (TIMI) Study Group, Division of Cardiovascular Medicine, Brigham and Women's Hospital (S.D.W., M.P.B., T.A.Z., J.F.K., S.A.M., D.L.B., C.T.R., M.S.S.), and the Cardiology Division, Massachusetts General Hospital (M.G.S.) - both in Boston; the Diabetes Unit, Hadassah Hebrew University Hospital, Jerusalem (I.R., O.M., A.C.); the Department of Cardiovascular Medicine, Kyoto University Graduate School of Medicine, Kyoto, Japan (E.T.K.); Li Ka Shing Knowledge Institute, St. Michael's Hospital, University of Toronto, Toronto (L.A.L.); the Division of Cardiology, University of Texas Southwestern Medical Center, Dallas (D.K.M.); Institute of Ageing and Chronic Disease, University of Liverpool, Liverpool, United Kingdom (J.P.H.W.); and AstraZeneca Gothenburg, Mölndal, Sweden (I.A.M.G.-N., M.F., P.A.J., A.-M.L.).

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1056/NEJMoa1812389DOI Listing
January 2019

Lorcaserin and Renal Outcomes in Obese and Overweight Patients in the CAMELLIA-TIMI 61 Trial.

Circulation 2019 Jan;139(3):366-375

TIMI Study Group, Division of Cardiovascular Medicine, Brigham and Women's Hospital, Boston, MA (B.M.S., E.A.B., A.Q., S.A.M., K.I., M.P.B., C.T.R., M.S.S., S.D.W.).

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1161/CIRCULATIONAHA.118.038341DOI Listing
January 2019

Assessing use of patient-focused pharmacotherapy in glycemic management through the Diabetes Collaborative Registry (DCR).

J Diabetes Complications 2018 Nov 9;32(11):1035-1039. Epub 2018 Aug 9.

Saint Luke's Mid America Heart Institute, Kansas, MO, United States of America; University of Missouri-Kansas City, Kansas, MO, United States of America.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.jdiacomp.2018.02.009DOI Listing
November 2018

Sex differences in management and outcomes of patients with type 2 diabetes and cardiovascular disease: A report from TECOS.

Diabetes Obes Metab 2018 10 19;20(10):2379-2388. Epub 2018 Jun 19.

Diabetes Trials Unit, Oxford Centre for Diabetes, Endocrinology and Metabolism, University of Oxford, Oxford, UK.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1111/dom.13377DOI Listing
October 2018

Effects of sodium glucose co-transporter 2 inhibitors on the kidney.

Diab Vasc Dis Res 2018 09 2;15(5):375-386. Epub 2018 Jul 2.

1 Department of Internal Medicine, University of Texas Southwestern Medical Center, Dallas, TX, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1177/1479164118783756DOI Listing
September 2018

Cardiovascular Safety of Lorcaserin in Overweight or Obese Patients.

N Engl J Med 2018 09 26;379(12):1107-1117. Epub 2018 Aug 26.

From the Thrombolysis in Myocardial Infarction (TIMI) Study Group, Division of Cardiovascular Medicine, Brigham and Women's Hospital, Boston (E.A.B., S.D.W., J.K., K.I., A.Q., M.P.B., C.T.R., M.S.S., B.M.S.); the Cardiovascular Division, University of Texas Southwestern Medical Center, Dallas (D.K.M.); the Section of Endocrinology, Yale School of Medicine, New Haven, CT (S.E.I.); the Department of Medicine, University of Minnesota, Minneapolis (C.L.F.); the Partners Clinical Research Centre, Nassau, Bahamas (C.B.); the Department of Cardiology, Postgraduate Medical School, Grochowski Hospital, Warsaw, Poland (A.B.); Cardiolink Clinical Trials, Monterrey, Mexico (A.G.-C.); McMaster University, Brampton, ON (M.G.), and the Division of Endocrinology and Metabolism, St. Michael's Hospital, University of Toronto, Toronto (L.A.L.) - both in Canada; MedStar Health Research Institute, Hyattsville, MD (N.J.W.); the Cardiology Department, Auckland City Hospital, Auckland, New Zealand (H.D.W.); Eisai, Woodcliff Lake, NJ (T.P., B.F., W.M., C.P., S.D.); National Health and Medical Research Council Clinical Trials Centre, University of Sydney, Sydney (A.C.K.); and the Translational Research Institute for Metabolism and Diabetes, Florida Hospital and the Sanford-Burnham Institute, Winter Park (S.R.S.).

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1056/NEJMoa1808721DOI Listing
September 2018

Risk Factors, Mortality, and Cardiovascular Outcomes in Patients with Type 2 Diabetes.

N Engl J Med 2018 08;379(7):633-644

From the Department of Molecular and Clinical Medicine, Institute of Medicine (Aidin Rawshani, Araz Rawshani, B.E., A. Rosengren, S.G.), and the Health Metrics Unit, Sahlgrenska Academy (S.F.), University of Gothenburg, and the Swedish National Diabetes Register, Center of Registers in Region (Aidin Rawshani, Araz Rawshani, S.F., B.E., A.-M.S., M.M., S.G.), Gothenburg, and the Department of Public Health and Caring Sciences-Geriatrics, Uppsala University, and the Swedish Medical Products Agency, Uppsala (B.Z.) - all in Sweden; the Institute of Cardiovascular and Medical Sciences, University of Glasgow, Glasgow, United Kingdom (N.S.); and the Division of Cardiology, Department of Internal Medicine, University of Texas Southwestern Medical Center, Dallas (D.K.M.).

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1056/NEJMoa1800256DOI Listing
August 2018

Pathways to Cardiorenal Complications in Type 2 Diabetes Mellitus: A Need to Rethink.

Circulation 2018 Jul;138(1):7-9

University of Texas Southwestern Medical Center, Dallas (D.K.M.).

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1161/CIRCULATIONAHA.118.035083DOI Listing
July 2018

Should Metformin Remain First-Line Medical Therapy for Patients with Type 2 Diabetes Mellitus and Atherosclerotic Cardiovascular Disease? An Alternative Approach.

Curr Diab Rep 2018 Jul 14;18(9):64. Epub 2018 Jul 14.

Department of Internal Medicine, University of Texas Southwestern Medical Center, 5323 Harry Hines Blvd, Dallas, TX, 75390-8830, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1007/s11892-018-1035-zDOI Listing
July 2018

DECLARE-TIMI 58: Participants' baseline characteristics.

Diabetes Obes Metab 2018 05 14;20(5):1102-1110. Epub 2018 Feb 14.

TIMI Study Group, Division of Cardiovascular Medicine, Brigham and Women's Hospital, and Harvard Medical School, Boston, Massachusetts.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1111/dom.13217DOI Listing
May 2018

Safety of a two-dose investigational hepatitis B vaccine, HBsAg-1018, using a toll-like receptor 9 agonist adjuvant in adults.

Vaccine 2018 05 5;36(19):2604-2611. Epub 2018 Apr 5.

Dynavax Technologies Corporation, 2929 Seventh Street, Suite 100, Berkeley, CA 94710, United States. Electronic address:

View Article

Download full-text PDF

Source
https://linkinghub.elsevier.com/retrieve/pii/S0264410X183043
Publisher Site
http://dx.doi.org/10.1016/j.vaccine.2018.03.067DOI Listing
May 2018

Effects of Sotagliflozin Added to Insulin in Patients with Type 1 Diabetes.

N Engl J Med 2017 12 13;377(24):2337-2348. Epub 2017 Sep 13.

From the University of Colorado Denver, Aurora (S.K.G.); the University of California at San Diego, San Diego (R.R.H.); Lexicon Pharmaceuticals, The Woodlands (P.B., D.G.-P., P.L., P.S.), the University of Texas Southwestern Medical Center, Dallas (D.K.M.), and Baylor College of Medicine and Texas Children's Hospital, Houston (J.A.K.) - all in Texas; the Diabetes Research Center, University of North Carolina School of Medicine, Durham (J.B.B.); the University of Leicester and University Hospitals of Leicester NHS Trust, Leicester, United Kingdom (M.J.D.); the University of Sydney, Sydney (G.R.F.); University Campus Bio-Medico of Rome, Rome (P.P.); Vall d'Hebron Research Institute, Barcelona, and CIBERDEM-Instituto de Salud Carlos III, Madrid (R.S.); Diabetes Center Auf der Bult, Hannover Medical School, Hannover, Germany (T.D.); and the University of Southern California, Los Angeles (A.P.).

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1056/NEJMoa1708337DOI Listing
December 2017

The association between HDL particle concentration and incident metabolic syndrome in the multi-ethnic Dallas Heart Study.

Diabetes Metab Syndr 2017 Nov 12;11 Suppl 1:S175-S179. Epub 2016 Dec 12.

Department of Cardiology, UT Southwestern Medical Center, United States. Electronic address:

View Article

Download full-text PDF

Source
https://linkinghub.elsevier.com/retrieve/pii/S18714021163026
Publisher Site
http://dx.doi.org/10.1016/j.dsx.2016.12.028DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6190917PMC
November 2017

Hypertension Control in Adults With Diabetes Mellitus and Recurrent Cardiovascular Events: Global Results From the Trial Evaluating Cardiovascular Outcomes With Sitagliptin.

Hypertension 2017 11 28;70(5):907-914. Epub 2017 Aug 28.

From the Duke Clinical Research Institute, Duke University School of Medicine, Durham, NC (A.M.N., D.S.G., Y.L., J.B.G., E.D.P.); Division of Cardiology, University of Texas Southwestern Medical Center, Dallas (D.K.M.); Canadian VIGOUR Centre, University of Alberta, Edmonton, Canada (P.W.A.); Division of Endocrinology, University of North Carolina School of Medicine, Chapel Hill (J.B.B.); Merck Research Laboratories, Merck & Co., Inc., Kenilworth, NJ (S.S.E.); The George Washington University Biostatistics Center, Rockville, MD (J.M.L.); Munich Diabetes Research Institute, Helmholtz Center, Germany (E.S.); Department of Cardiovascular Sciences, University of Leuven, Belgium (F.V.d.W.); and Diabetes Trials Unit, Oxford Centre for Diabetes, Endocrinology, and Metabolism, University of Oxford, Churchill Hospital, United Kingdom (R.R.H.).

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1161/HYPERTENSIONAHA.117.09482DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5638706PMC
November 2017

Cardiovascular adverse events in the drug-development program of bupropion for smoking cessation: A systematic retrospective adjudication effort.

Clin Cardiol 2017 Oct 12;40(10):899-906. Epub 2017 Jun 12.

Stanford Center for Clinical Research, Department of Medicine, Stanford University School of Medicine, Stanford, California.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1002/clc.22744DOI Listing
October 2017

Major Bleeding in Patients With Diabetes and Atrial Fibrillation Treated With New Oral Anticoagulants-Reply.

JAMA Cardiol 2017 Oct;2(10):1168

TIMI Study Group, Cardiovascular Division, Brigham and Women's Hospital, Boston, Massachusetts.

View Article

Download full-text PDF

Source
http://cardiology.jamanetwork.com/article.aspx?doi=10.1001/j
Publisher Site
http://dx.doi.org/10.1001/jamacardio.2017.2034DOI Listing
October 2017

Diabetes medications and cardiovascular outcome trials: Lessons learned.

Cleve Clin J Med 2017 Oct;84(10):759-767

Department of Internal Medicine, Division of Cardiology, University of Texas Southwestern Medical Center, Dallas, TX, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.3949/ccjm.84gr.17006DOI Listing
October 2017

Longitudinal changes in serum 25-hydroxyvitamin D in the Dallas Heart Study.

Clin Endocrinol (Oxf) 2017 Sep 14;87(3):242-248. Epub 2017 Jun 14.

Department of Internal Medicine, University of Texas Southwestern Medical Center, Dallas, TX, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1111/cen.13374DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5561481PMC
September 2017

Secondary Prevention of Cardiovascular Disease in Patients With Type 2 Diabetes Mellitus: International Insights From the TECOS Trial (Trial Evaluating Cardiovascular Outcomes With Sitagliptin).

Circulation 2017 Sep 16;136(13):1193-1203. Epub 2017 Jun 16.

From Duke Clinical Research Institute, Duke University School of Medicine, Durham, NC (N.J.P., A.M.N., K.S.P., J.B.G., Y.L., E.D.P.); Diabetes Trials Unit, Oxford Centre for Diabetes, Endocrinology and Metabolism, University of Oxford, United Kingdom (M.A.B., R.R.H.); Canadian VIGOUR Centre, University of Alberta, Edmonton, Canada (P.W.A.); St. Michael's Hospital, University of Toronto, Ontario, Canada (R.G.J.); Division of Cardiology, Department of Medicine, University of Texas Southwestern Medical Center, Dallas (D.K.M.); Noordwest Ziekenhuisgroep, Department of Cardiology, Alkmaar, the Netherlands (J.C.H.); Department of Cardiology, Oslo University Hospital, and University of Oslo, Norway (S.H.); University of Helsinki and Helsinki University Hospital, Finland (T.E.S.); University of Oulu, Center for Life Course Health Research, Finland (T.E.S.); and Department of Endocrinology and Metabolism, School of Medicine (Kastamonu), Hacettepe University, Ankara, Turkey (T.D.).

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1161/CIRCULATIONAHA.117.027252DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5614823PMC
September 2017

Residual Angina After Elective Percutaneous Coronary Intervention in Patients With Diabetes Mellitus.

Circ Cardiovasc Qual Outcomes 2017 Sep;10(9)

From the Saint Luke's Mid America Heart Institute, Kansas City, MO (A.G., M.K., F.T., P.G.J., J.A.S., J.-S.J., S.V.A.); University of Missouri-Kansas City (A.G., M.K., J.A.S., S.V.A.); Division of Cardiology, University of Texas Southwestern Medical Center, Dallas (D.K.M.); The Queen Elizabeth Hospital Discipline of Medicine, University of Adelaide, Central Adelaide Local Health Network, Australia (J.F.B.); Division of Cardiology, Emory University School of Medicine, Atlanta, GA (A.G.); Massachusetts General Hospital Department of Medicine, Boston, MA (N.M.B.); and Division of Cardiology, Beth Israel Deaconess Medical Center, Boston (R.W.Y.).

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1161/CIRCOUTCOMES.117.003553DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5611809PMC
September 2017

Efficacy and Safety of Degludec versus Glargine in Type 2 Diabetes.

N Engl J Med 2017 08 12;377(8):723-732. Epub 2017 Jun 12.

From the Research Medical Center, Kansas City, MO (S.P.M.); University of Texas Southwestern Medical Center, Dallas (D.K.M.); Lunenfeld-Tanenbaum Research Institute, Mount Sinai Hospital, University of Toronto, Toronto (B.Z.); Imperial Clinical Trials Unit, Imperial College London, London (N.R.P.); University of Washington, Seattle (S.S.E.); Medical University of Graz, Graz, Austria (T.R.P.); Florida Hospital Translational Research Institute for Metabolism and Diabetes and Sanford Burnham Prebys Medical Discovery Institute, Orlando (R.E.P.); Novo Nordisk, Søborg, Denmark (P.-M.H., M.L., K.B.-F., A.M., S.S., K.K.); and University of North Carolina School of Medicine, Chapel Hill (J.B.B.).

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1056/NEJMoa1615692DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5731244PMC
August 2017

Dual antiplatelet therapy in patients with diabetes and acute coronary syndromes managed without revascularization.

Am Heart J 2017 Jun 27;188:156-166. Epub 2017 Mar 27.

Duke Clinical Research Institute, Durham, NC, USA; Division of Cardiology, Department of Medicine, Duke University School of Medicine, Durham, NC, USA. Electronic address:

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.ahj.2017.03.015DOI Listing
June 2017

Integration of recent evidence into management of patients with atherosclerotic cardiovascular disease and type 2 diabetes.

Lancet Diabetes Endocrinol 2017 05 26;5(5):391-402. Epub 2017 Jan 26.

Cardiology Unit, Department of Medicine Solna, Karolinska Institutet, Stockholm, Sweden.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/S2213-8587(17)30033-5DOI Listing
May 2017

Multimodality Strategy for Cardiovascular Risk Assessment: Performance in 2 Population-Based Cohorts.

Circulation 2017 05 30;135(22):2119-2132. Epub 2017 Mar 30.

From Departments of Medicine (J.A.d.L., B.L., J.P.B., D.K.M., M.H.D., A.K.) and Clinical Sciences (C.R.A., J.D.B., D.K.M.), University of Texas Southwestern Medical Center, Dallas; Institute for Exercise and Environmental Medicine, Texas Health Presbyterian, Dallas (B.L.); Inova Heart and Vascular Institute, Fall Church, VA (C.R.d.); Department of Medicine, Vanderbilt University Medical Center, Nashville, TN (T.J.W.); Departments of Medicine and Radiological Sciences, Wake Forest Health Sciences, Winston-Salem, NC (W.G.H.); Department of Medicine, University of Maryland School of Medicine, Baltimore (S.L.S.); The Johns Hopkins University School of Medicine, Baltimore, MD (P.O.); Los Angeles Biomedical Research Institute, CA (M.B.); Departments of Preventive Medicine and Medicine, Northwestern University Feinberg School of Medicine, Chicago, IL (P.G.); and Baylor College of Medicine, Houston, TX (G.M.B.).

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1161/CIRCULATIONAHA.117.027272DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5486874PMC
May 2017

Corrections needed to 2016 ESC and AHA guidelines on heart failure.

Lancet Diabetes Endocrinol 2017 05 5;5(5):325-326. Epub 2017 Apr 5.

Diabetes Trials Unit, Oxford Centre for Diabetes, Endocrinology, and Metabolism, University of Oxford, Oxford, UK.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/S2213-8587(17)30102-XDOI Listing
May 2017

Evacetrapib and Cardiovascular Outcomes in High-Risk Vascular Disease.

N Engl J Med 2017 05;376(20):1933-1942

From the Cleveland Clinic Coordinating Center for Clinical Research (C5Research), Department of Cardiovascular Medicine, Cleveland Clinic, Cleveland (A.M.L., V.M., E.M., K.W., D.M., S.E.N.); South Australian Heart and Medical Research Institute, University of Adelaide, Adelaide (S.J.N.), and School of Medical Sciences, University of New South Wales, Sydney (P.J.B.) - both in Australia; Eli Lilly, Indianapolis (J.S.R., G.R., B.V., G.W.); Washington Cardiovascular Associates, Medstar Research Institute, Washington, DC (H.B.B.); Centre for Cardiovascular Science, University of Edinburgh, Edinburgh (K.A.A.F.); Beth Israel Deaconess Medical Center, Boston (C.M.G.); Duke University Medical Center, Durham, NC (C.G.); Université Sorbonne Paris 6, ACTION Study Group, Hôpital Pitié-Salpêtrière, Assistance Publique-Hôpitaux de Paris, Institut de Cardiologie, Paris (G.M.); Penn Heart and Vascular Center, Philadelphia (D.R.); Columbia University, New York (A.R.T.), and Saratoga Cardiology Associates, Saratoga Springs (D.K.) - both in New York; St. Michael's Hospital, Toronto (S.G.), Recherche Médicale Saint-Jérôme, Saint-Jérôme, QC (Y.P.), and Centre de Santé et de Services Sociaux du Nord de Lanaudière-Centre Hospitalier Régional de Lanaud, Saint-Charles-Borromée, QC (S.K.) - all in Canada; Instituto Cardiovascular de Buenos Aires, Buenos Aires (D.C.); University of Texas Southwestern Medical Center, Dallas (D.K.M.); Heart Institute (InCor)-University of São Paulo Medical School, São Paulo (J.C.N.); Hospital Central Dr. Ignacio Morones Prieto, San Luis Potosi, Mexico (J.L.L.-P.); the First Affiliated Hospital of Harbin Medical University, Harbin, China (W.L.); and South Oklahoma Heart Research, Oklahoma City (N.T.).

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1056/NEJMoa1609581DOI Listing
May 2017

Assessing the Safety of Sitagliptin in Older Participants in the Trial Evaluating Cardiovascular Outcomes with Sitagliptin (TECOS).

Diabetes Care 2017 Apr 5;40(4):494-501. Epub 2017 Jan 5.

Diabetes Trials Unit, Oxford Centre for Diabetes, Endocrinology and Metabolism, University of Oxford, Oxford, U.K.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.2337/dc16-1135DOI Listing
April 2017

Atrial Fibrillation, Type 2 Diabetes, and Non-Vitamin K Antagonist Oral Anticoagulants: A Review.

JAMA Cardiol 2017 Apr;2(4):442-448

TIMI Study Group, Cardiovascular Division, Brigham and Women's Hospital, Boston, Massachusetts.

View Article

Download full-text PDF

Source
http://cardiology.jamanetwork.com/article.aspx?doi=10.1001/j
Publisher Site
http://dx.doi.org/10.1001/jamacardio.2016.5224DOI Listing
April 2017

Mortality and Cardiovascular Disease in Type 1 and Type 2 Diabetes.

N Engl J Med 2017 04;376(15):1407-1418

From the Department of Molecular and Clinical Medicine, Institute of Medicine, University of Gothenburg (Aidin Rawshani, Araz Rawshani, B.E., A. Rosengren, S.G.), and the Swedish National Diabetes Register, Center of Registers in Region (Aidin Rawshani, Araz Rawshani, S.F., B.E., A.-M.S., M.M., S.G.), Gothenburg, Sweden; the Division of Cardiology, Department of Internal Medicine, University of Texas Southwestern Medical Center, Dallas (D.K.M.); and the Institute of Cardiovascular and Medical Sciences, University of Glasgow, Glasgow, United Kingdom (N.S.).

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1056/NEJMoa1608664DOI Listing
April 2017

Range of Risk Factor Levels: Control, Mortality, and Cardiovascular Outcomes in Type 1 Diabetes Mellitus.

Circulation 2017 Apr 22;135(16):1522-1531. Epub 2017 Feb 22.

From Department of Molecular and Clinical Medicine, Institute of Medicine, University of Gothenburg, Sweden (Aidin Rawshani, Araz Rawshani, B.E., A. Rosengren); Swedish National Diabetes Register, Center of Registers in Region, Gothenburg, Sweden (Aidin Rawshani, Araz Rawshani, S.F., B.E., A.-M.S., M.M., S.G.); Division of Cardiology, Department of Internal Medicine, University of Texas Southwestern Medical Center, Dallas (D.K.M.); and Institute of Cardiovascular and Medical Sciences, University of Glasgow, Glasgow, UK (N.S.).

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1161/CIRCULATIONAHA.116.025961DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5400410PMC
April 2017

Impact of empagliflozin in patients with diabetes and heart failure.

Trends Cardiovasc Med 2017 02 4;27(2):144-151. Epub 2016 Aug 4.

Division of Cardiology, Department of Internal Medicine, University of Texas Southwestern Medical Center, 5323 Harry Hines Blvd Dallas, TX 75390-8830. Electronic address:

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.tcm.2016.07.008DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5253088PMC
February 2017

Sex-Based Differences in Cardiometabolic Biomarkers.

Circulation 2017 02;135(6):544-555

From Departments of Medicine (J.L., M.S., D.K.M., M.O.G., I.N., J.D.B., A.K., A.R., J.A.d.L.) and Clinical Sciences (C.R.A., D.K.M., J.D.B.), UT Southwestern Medical Center, Dallas, TX; Division of Medicine, Akershus University Hospital, Lørenskog, and University of Oslo, Norway (T.O.); Department of Clinical Pharmacology and Toxicology, University Medical Centre Hamburg-Eppendorf, Hamburg, Germany (D.A.); and Department of Cardiovascular Medicine, University of Oxford, United Kingdom (D.A.).

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1161/CIRCULATIONAHA.116.023005DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5302552PMC
February 2017

A Test in Context: Hemoglobin A and Cardiovascular Disease.

J Am Coll Cardiol 2016 Dec;68(22):2479-2486

Department of Internal Medicine, University of Texas Southwestern Medical Center, Dallas, Texas.

View Article

Download full-text PDF

Source
http://content.onlinejacc.org/data/Journals/JAC/935902/08070
Web Search
http://dx.doi.org/10.1016/j.jacc.2016.08.070DOI Listing
December 2016

Sodium-glucose cotransporter-2 inhibition for the reduction of cardiovascular events in high-risk patients with diabetes mellitus.

Eur Heart J 2016 Nov 5;37(42):3192-3200. Epub 2016 May 5.

Division of Cardiology, Department of Internal Medicine, University of Texas Southwestern Medical Center, Dallas, TX, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1093/eurheartj/ehw110DOI Listing
November 2016

A Safety Evaluation of Empagliflozin for the Treatment of Type 2 Diabetes.

Expert Opin Drug Saf 2016 2;15(3):393-402. Epub 2016 Feb 2.

a Division of Cardiology , University of Texas Southwestern Medical Center , Dallas , TX , USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1517/14740338.2016.1135900DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4890479PMC
October 2016

Predicting Adverse Outcomes After Myocardial Infarction Among Patients With Diabetes Mellitus.

Circ Cardiovasc Qual Outcomes 2016 07 24;9(4):372-9. Epub 2016 May 24.

From the Saint Luke's Mid America Heart Institute, Kansas City, MO (S.V.A., J.A.S., P.G.J., M.K.); University of Missouri-Kansas City (S.V.A., J.A.S., M.K.); University of Texas Southwestern Medical Center, Dallas (D.K.M.); Yale University School of Medicine, New Haven, CT (K.J.L.); Genentech, South San Francisco, CA (Y.X.); Saint Louis University, St. Louis, MO (J.M.S.); and Emory School of Medicine, Atlanta, GA (A.G.).

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1161/CIRCOUTCOMES.115.002365DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5341790PMC
July 2016

Revascularization Trends in Patients With Diabetes Mellitus and Multivessel Coronary Artery Disease Presenting With Non-ST Elevation Myocardial Infarction: Insights From the National Cardiovascular Data Registry Acute Coronary Treatment and Intervention Outcomes Network Registry-Get with the Guidelines (NCDR ACTION Registry-GWTG).

Circ Cardiovasc Qual Outcomes 2016 05 10;9(3):197-205. Epub 2016 May 10.

From the Department of Internal Medicine, Division of Cardiology, UT Southwestern Medical Center, Dallas, TX (A.P., D.K.M., J.A.d.L., S.R.D., J.D.B., E.S.B., S.B., S.P.M., D.J.K.); Veterans Affairs North Texas Health Care System, Dallas, TX (E.S.B., S.B.); Division of Cardiology, Mayo Clinic, Rochester, MN (G.W.B.); Department of Medicine, Division of Cardiology, Duke Clinical Research Institute, Durham, NC (D.N.S., M.R.); Department of Medicine, Division of Cardiology, Emory University School of Medicine, Atlanta, GA (A.G.); Department of Medicine, Saint Luke's Mid America Heart Institute and University of Missouri-Kansas City, Kansas City, MO (M.K.); and Department of Internal Medicine, University of California Davis, Sacramento, CA (E.A.A.).

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1161/CIRCOUTCOMES.115.002084DOI Listing
May 2016

Heart Failure Considerations of Antihyperglycemic Medications for Type 2 Diabetes.

Circ Res 2016 05;118(11):1830-43

From the Munich Diabetes Research Group e.V. at Helmholtz Center, Neuherberg, Germany (E.S., O.S.); and Division of Cardiology, Department of Internal Medicine, University of Texas Southwestern Medical Center, Dallas, TX (D.K.M.).

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1161/CIRCRESAHA.116.306924DOI Listing
May 2016

Cardiovascular Outcomes of Patients in SAVOR-TIMI 53 by Baseline Hemoglobin A1c.

Am J Med 2016 Mar 31;129(3):340.e1-8. Epub 2015 Oct 31.

Thrombolysis in Myocardial Infarction (TIMI) Study Group, Heart and Vascular Center, Brigham and Women's Hospital, and Harvard Medical School, Boston, Mass. Electronic address:

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.amjmed.2015.09.022DOI Listing
March 2016

Effect of treatment with rosiglitazone on high-sensitivity cardiac troponin levels among patients with type 2 diabetes mellitus.

Diab Vasc Dis Res 2016 Mar 23;13(2):113-8. Epub 2015 Dec 23.

Division of Cardiology, Department of Internal Medicine, University of Texas Southwestern Medical Center, Dallas, TX, USA Department of Clinical Sciences, University of Texas Southwestern Medical Center, Dallas, TX, USA

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1177/1479164115618517DOI Listing
March 2016

Coronary Artery Calcium Improves Risk Classification in Younger Populations.

JACC Cardiovasc Imaging 2015 Nov 14;8(11):1285-93. Epub 2015 Oct 14.

Department of Internal Medicine, University of Texas Southwestern Medical Center, Dallas, Texas; Division of Cardiology, University of Texas Southwestern Medical Center, Dallas, Texas. Electronic address:

View Article

Download full-text PDF

Source
http://imaging.onlinejacc.org/data/Journals/JCMG/934677/0601
Web Search
http://linkinghub.elsevier.com/retrieve/pii/S1936878X1500665
Publisher Site
http://dx.doi.org/10.1016/j.jcmg.2015.06.015DOI Listing
November 2015

Effect of Extended-Release Niacin on Saphenous Vein Graft Atherosclerosis: Insights from the Atherosclerosis Lesion Progression Intervention Using Niacin Extended Release in Saphenous Vein Grafts (ALPINE-SVG) Pilot Trial.

J Invasive Cardiol 2015 Oct;27(10):E204-10

VA North Texas Health Care System, The University of Texas Southwestern Medical Center at Dallas, Division of Cardiology (111A), 4500 S. Lancaster Rd, Dallas, TX 75216 USA.

View Article

Download full-text PDF

Source
October 2015

High prevalence of elevated haemoglobin A1C among adolescent blood donors: Results from a voluntary screening programme including 31,546 adolescents.

Diab Vasc Dis Res 2015 Jul 13;12(4):272-8. Epub 2015 May 13.

Carter BloodCare, Bedford, TX, USA Department of Pathology, University of Texas Southwestern Medical Center, Dallas, TX, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1177/1479164115579799DOI Listing
July 2015

Predicting cardiovascular risk in type 2 diabetes: the heterogeneity challenges.

Curr Cardiol Rep 2015 Jul;17(7):607

Department of Internal Medicine, Division of Cardiology, University of Texas Southwestern Medical Center, Dallas, TX, USA,

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1007/s11886-015-0607-7DOI Listing
July 2015

Effect of Sitagliptin on Cardiovascular Outcomes in Type 2 Diabetes.

N Engl J Med 2015 Jul 8;373(3):232-42. Epub 2015 Jun 8.

From the Duke Clinical Research Institute, Duke University School of Medicine, Durham (J.B.G., J.G., M.J.P., E.D.P.) and University of North Carolina School of Medicine, Chapel Hill (J.B.B.) - both in North Carolina; Diabetes Trials Unit, Oxford Centre for Diabetes, Endocrinology and Metabolism, University of Oxford, Oxford, United Kingdom (M.A.B., R.R.H.); Canadian VIGOUR Centre, University of Alberta, Edmonton, AB (P.W.A.) and St. Michael's Hospital, University of Toronto, Toronto (R.J.) - both in Canada; Merck, Kenilworth, NJ (S.S.E., K.D.K., J.K., S.K., P.P.S., S.S.); George Washington University Biostatistics Center, Rockville, MD (J.M.L.); University of Texas Southwestern Medical Center, Dallas (D.K.M.); Munich Diabetes Research Group, Helmholtz Center, Neuherberg, Germany (E.S.); and University of Leuven, Leuven, Belgium (F.V.W.).

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1056/NEJMoa1501352DOI Listing
July 2015

Recognition of incident diabetes mellitus during an acute myocardial infarction.

Circ Cardiovasc Qual Outcomes 2015 May 21;8(3):260-7. Epub 2015 Apr 21.

From the Saint Luke's Mid America Heart Institute, Kansas City, MO (S.V.A., P.G.J., J.A.S., M.K.); University of Missouri-Kansas City (S.V.A., J.A.S., M.K.); Saint Louis University, MO (J.M.S.); Yale University School of Medicine, New Haven, CT (K.J.L., S.E.I.); University of Texas Southwestern Medical Center, Dallas (D.K.M.); Emory School of Medicine, Atlanta, GA (A.G.); VA Eastern Colorado Health Care System, Denver (T.M.M.); University of Gothenburg, Gothenburg, Sweden (M.L.); and Cleveland Clinic Foundation, OH (D.G.).

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1161/CIRCOUTCOMES.114.001452DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4439264PMC
May 2015